Notification of Allotment of Securities

Capital Change Notice




Section 1: Issuer information
Name of issuer Heartland Group Holdings
Limited
NZX ticker code HGH
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZHGHE0007S9
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 4,336,812
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $1.63699813
Nature of the payment (for example, cash or other
consideration)
Consideration satisfied pursuant
to the Dividend Reinvestment
Plan
Amount paid up (if not in full) Fully paid ordinary shares
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury
Stock, in existence)
1

0.61% of the total number of fully
paid ordinary shares prior to this
issue
For an issue of Convertible Financial Products or Options,
the principal terms of Conversion (for example the
Conversion price and Conversion date and the ranking of
the Financial Product in relation to other Classes of
Financial Product) or the Option (for example, the exercise
price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific
authority for issue/acquisition/redemption/ (the reason for
change must be identified here)
Issue of ordinary shares to those
shareholders that have elected to
participate in the HGH Dividend
Reinvestment Plan, approved by
directors’ resolutions.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding
Treasury Stock) and the total number of Financial Products
of the Class held as Treasury Stock after the
issue/acquisition/redemption.
709,658,200 ordinary shares
(excluding Treasury Stock)

877,737 Treasury Stock
In the case of an acquisition of shares, whether those
shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Directors’ resolution
Issue of Ordinary Shares under
Listing Rule 4.8.1

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
Pursuant to the terms of the HGH
Dividend Reinvestment Plan
Offer Document dated 10
December 2018
Date of issue/acquisition/redemption
2
22/03/2023
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement
Andrew Dixson, Chief Financial
Officer
Contact person for this announcement
Nicola Foley, Group Head of
Communications
Contact phone number 027 345 6809
Contact email address Nicola.Foley@heartland.co.nz
Date of release through MAP

22/03/2023




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).